CDDO to Treat Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Xeloda and Radiotherapy for Bone Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
rhEndostatin Protein Involving Pediatric Patients With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clofarabine in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Study of S-3304 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1